An experimental animal model of fulminant hepatic failure in pigs

被引:6
作者
Lee, KU
Zheng, LX
Cho, YB
Kim, KH
Ha, J
Suh, KS
Jung, SE
机构
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea
[2] Harbin Med Coll, Affiliated Hosp 2, Dept Surg, Harbin, Peoples R China
关键词
models; animal; liver failure; acute; hepatic artery; hepatic encephalopathy;
D O I
10.3346/jkms.2005.20.3.427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to develop an experimental animal model of fulminant hepatic failure to test the efficacy of the bioartificial liver system. The portal vein and the hepatic artery were clamped intermittently and then the hepatic artery was ligated (ligation group, n = 5). Pigs whose hepatic arteries were not ligated after clamping were assigned to the non-ligation group (n = 5). The biochemical changes in blood, histologic alterations of the liver and neurologic examination for pigs were checked up. All animals died within 17 hr in the ligation group. On the other hand, all animals survived more than 7 days in the non-ligation group. In the ligation group, the levels of ammonia, lactic acid and creatinine showed a progressively increasing pattern. Prothrombin time was also prolonged gradually. Cytoplasmic condensation and nuclear pyknosis of hepatocytes were detected histologically at autopsy. Neurologic findings such as decreased pain sensation, tachypnea and no light reflex of pupils were observed. The findings shown in the ligation group are similar to the clinical features of fulminant hepatic failure in human and this animal model is reproducible. Therefore, this can be a suitable animal model to evaluate the efficacy of the bioartificial liver system for treating fulminant hepatic failure.
引用
收藏
页码:427 / 432
页数:6
相关论文
共 50 条
  • [31] Fulminant hepatic failure caused by herbal supplies
    Santos Junior, Genario Oliveira
    Ferreira Filho, Raymundo Parana
    de Codes Foulon, Liana Machado
    Costa Beisl Noblat, Lucia de Araujo
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54 (03)
  • [32] INHIBITORS OF HEPATIC DNA-SYNTHESIS IN FULMINANT HEPATIC-FAILURE
    HUGHES, RD
    YAMADA, H
    GOVE, CD
    WILLIAMS, R
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (06) : 816 - 819
  • [33] Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model
    Matkowskyj, KA
    Marrero, JA
    Carroll, RE
    Danilkovich, AV
    Green, RM
    Benya, RV
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 277 (02): : G455 - G462
  • [34] Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
    Avraham, Y.
    Grigoriadis, N. C.
    Poutahidis, T.
    Vorobiev, L.
    Magen, I.
    Ilan, Y.
    Mechoulam, R.
    Berry, E. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (07) : 1650 - 1658
  • [35] SULFASALAZINE-INDUCED FULMINANT HEPATIC-FAILURE
    MARINOS, G
    RILEY, J
    PAINTER, DM
    MCCAUGHAN, GW
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 14 (02) : 132 - 135
  • [36] INTRACRANIAL PRESSURE MONITORING IN CHILDREN WITH FULMINANT HEPATIC FAILURE
    Paiva, W. S.
    de Andrade, A. F.
    Amorim, R. L. O.
    Figueiredo, E. G.
    Matushita, H.
    Teixeira, M. J.
    REVISTA DE NEUROLOGIA, 2009, 48 (03) : 134 - 136
  • [37] Fulminant Hepatic Failure in the Context of Reinstituting Valproate Use
    Rej, Soham
    Chen, Tianyan
    Edwards, Marcel
    Zicherman, Viviane
    PSYCHOSOMATICS, 2014, 55 (03) : 303 - 304
  • [38] Xylitol intoxication associated with fulminant hepatic failure in a dog
    Todd, Jeffrey A.
    Powell, Lisa L.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2007, 17 (03) : 286 - 289
  • [39] Pediatric Fulminant Hepatic Failure: Are We Improving Outcome?
    Bunchman, Timothy
    CRITICAL CARE MEDICINE, 2016, 44 (10) : 1949 - 1949
  • [40] Acute Iron Poisoning: A Case of Fulminant Hepatic Failure
    Bourbon Ruao, Maria
    Pestana, Ines
    Passos, Rita
    Monte, Julia Raquel
    Marinho, Anibal
    ACTA MEDICA PORTUGUESA, 2024, 37 (06) : 470 - 472